Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals

The emerging COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has raised a global catastrophe. To date, there is no specific antiviral drug available to combat this virus, except the vaccine. In this study, the main protease (M(pro)) required for SARS-CoV-2 vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Le-Yun, Chen, Cheng, Su, Jianpeng, Li, Jia-Qi, Jiang, Zhihui, Gao, Han, Chigan, Jia-Zhu, Ding, Huan-Huan, Zhai, Le, Yang, Ke-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026246/
https://www.ncbi.nlm.nih.gov/pubmed/33915460
http://dx.doi.org/10.1016/j.bioorg.2021.104889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026246/
https://www.ncbi.nlm.nih.gov/pubmed/33915460
http://dx.doi.org/10.1016/j.bioorg.2021.104889

Ejemplares similares